Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Syste…
Industry Peers
Electrical Equipment & Parts| Headline | Source | Time |
|---|---|---|
This week | ||
Older | ||
MMerkur | ||
 At €9.22, Is It Time To Put Hoenle AG (ETR:HNL) On Your Watch List? Hoenle AG ( ETR:HNL ), might not be a large cap stock, but it received a lot of attention from a substantial price... | ||
Investors in Hoenle (ETR:HNL) have unfortunately lost 84% over the last five years Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Anyone who held Hoenle... | ||
 Heineken’s Strongbow adds NaviLens levels to packaging The cider brand has added a high-contrast NaviLens QR code to its cans. | ||
 3 firms to lay off hundreds of North Jersey-based employees BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty | ||
 Novartis to acquire Tourmaline Bio for $1.4 billion Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a promising targeted therapy with the potential to reduce systemic inflammation, as a treatment option for atherosclerotic cardiovascular disease, Novartis said in a statement. With the deal, Novartis will acquire a Phase III-ready asset that will complement its existing cardiovascular disease portfolio, it said. | ||